This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Sannamu Lee - Innovator in Pulmonary Surfactant Compositions
Introduction
Sannamu Lee is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of medical science, particularly in the development of artificial pulmonary surfactant compositions. His work aims to address critical respiratory conditions, enhancing treatment options for patients.
Latest Patents
Sannamu Lee holds 1 patent for his invention titled "Artificial pulmonary surfactant compositions and use of the same." This innovative composition comprises a lipid mixture system that contains no protein or peptide, or a protein/peptide-lipid mixture. The artificial pulmonary surfactant composition is particularly useful for treating respiratory distress syndrome (RDS) and acute respiratory distress syndrome (ARDS). It also aids in mitigating respiratory insufficiencies caused by pneumonia and asthma, all while being cost-effective to produce.
Career Highlights
Throughout his career, Sannamu Lee has focused on advancing medical treatments through innovative solutions. His dedication to improving respiratory health has positioned him as a key figure in his field. His research and inventions have the potential to significantly impact patient care and treatment outcomes.
Collaborations
Sannamu Lee has collaborated with notable colleagues, including Yoshihiro Nakamura and Ko Yukikate. These partnerships have fostered a collaborative environment that enhances the development of innovative medical solutions.
Conclusion
Sannamu Lee's contributions to the field of pulmonary surfactant compositions demonstrate his commitment to improving respiratory health. His innovative approach and collaborative efforts continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile